ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Fox Chase Biochemist Automates DNA Production

July 20, 1990

Cooperative Group Massacre Hurt Some Of Best CCOPs Which May Go Unfunded

March 27, 1987

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

Duke wins Avon-NCI funding.

October 31, 2003

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012